Intra-Cellular Therapies
ITCI
#1806
Rank
NZ$15.28 B
Marketcap
$144.15
Share price
-0.43%
Change (1 day)
54.35%
Change (1 year)

Earnings for Intra-Cellular Therapies (ITCI)

Earnings in 2024 (TTM): -NZ$0.14 Billion

According to Intra-Cellular Therapies's latest financial reports the company's current earnings are NZ$0.56 Billion. In 2023 the company made an earning of -NZ$0.24 Billion, an increase over its 2022 earnings that were of -NZ$0.43 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Intra-Cellular Therapies from 2014 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.14 Billion-41.38%
2023 -NZ$0.24 Billion-45.74%
2022 -NZ$0.43 Billion-9.81%
2021 -NZ$0.48 Billion25.17%
2020 -NZ$0.38 Billion53.66%
2019 -NZ$0.25 Billion-4.77%
2018 -NZ$0.26 Billion56.96%
2017 -NZ$0.17 Billion-14.33%
2016 -NZ$0.2 Billion10.09%
2015 -NZ$0.18 Billion241.45%
2014 -NZ$51.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$13.66 Million-90.21%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$77.98 Million-44.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.3 Billion 108.31%๐Ÿ‡บ๐Ÿ‡ธ USA